Robin Swartz - 15 Mar 2023 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role: Chief Operating Officer
Signature: /s/ Robert Hesslein, as Attorney-in-Fact for Robin Swartz
Issuer symbol: VYGR
Transactions as of: 15 Mar 2023
Net transactions value: -$126,059
Form type: 4
Filing time: 17 Mar 2023, 16:37:20 UTC
Previous filing: 22 Feb 2023
Next filing: 22 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYGR	Common Stock	Sale	$126,059	-15,373	-17%	$8.20	76,530	15 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.16 to $8.251, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.16 to $8.251, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.